Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Use of Placental Alpha Microglobulin-1(PAMG-1) to Diagnose Premature Rupture of Membranes in Pregnant Women (PAMG-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03715530
Recruitment Status : Terminated (Data collection has halted due to no further assays provided by AmniSURE)
First Posted : October 23, 2018
Last Update Posted : October 23, 2018
Sponsor:
Collaborator:
AmniSure International LLC
Information provided by (Responsible Party):
Mark Santillan, University of Iowa

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : July 2011
  Actual Study Completion Date : July 2011